BioSpace News Archive

Pharm Country

NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing

NRx Pharmaceuticals, Inc. today announced that advice from regulatory counsel, which includes former senior officials from the Food and Drug Administration, supports filing two New Drug Applications (NDAs) in 2024.

June 28, 2024
·
8 min read
Business

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.

June 28, 2024
·
4 min read
Pharm Country

Amneal Releases 2023 Environmental, Social and Governance Report

Amneal Pharmaceuticals, Inc. announced the release of its fourth Environmental, Social and Governance Report.

June 28, 2024
·
9 min read
Pharm Country

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results

Intelligent Bio Solutions Inc. today announced the successful completion of the in-clinic portion of its pharmacokinetic (PK) study, a core component of the Company’s clinical study plan for its 510(k) pathway for regulatory approval.

June 28, 2024
·
4 min read
BioCapital

Mytonomy Joins the American Academy of Orthopaedic Surgeons’ PROMs Vendor Program

Mytonomy Inc., a leader in cloud solutions for health education and engagement, announced that the company is a proud participant of the American Academy of Orthopaedic Surgeons’ Patient-Reported Outcome Measures Vendor Program.

June 28, 2024
·
3 min read
Deals

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - June 28, 2024

Nevro Corp. announced that on June 7, 2024, the Compensation Committee of the Company’s Board of Directors granted inducement restricted stock unit awards covering 56,692 shares of Nevro’s common stock to 17 new non-executive employees to induce them to accept employment with Nevro.

June 28, 2024
·
2 min read
Deals

Fabric Acquires MeMD, Expanding Virtual Care Services to 30,000 Employers and 5 Million Members

Fabric, a leading healthcare technology company and care enablement system, announced the acquisition of MeMD from Walmart Inc. MeMD is a leading provider of virtual behavioral, urgent, and primary care benefits for 30,000 corporate, institutional, and health plan partners and 5 million members.

June 28, 2024
·
3 min read
Pharm Country

Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology

Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology.

June 28, 2024
·
4 min read
Deals

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

Cingulate Inc. today announced the entry into definitive agreements for the immediate exercise of certain outstanding Series A warrants to purchase up to an aggregate of 2,125,000 shares of common stock.

June 28, 2024
·
5 min read
Genetown

ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders

Oryzon Genomics, S.A. announced the voting results from its Annual General Meeting of Shareholders held in Madrid.

June 28, 2024
·
4 min read